These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31798809)

  • 1. The role of cardiac magnetic resonance (CMR) in the diagnosis of cardiomyopathy: A systematic review.
    Mayala HA; Bakari KH; Zhaohui W
    Malawi Med J; 2018 Dec; 30(4):291-295. PubMed ID: 31798809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Cardiac Magnetic Resonance (CMR) in the diagnosis of cardiomyopathy: A systematic review.
    Mayala HA; Bakari KH; Zhaohui W
    Malawi Med J; 2019 Sep; 31(3):241-245. PubMed ID: 31839897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
    Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
    Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry.
    Mizia-Stec K; Charron P; Gimeno Blanes JR; Elliott P; Kaski JP; Maggioni AP; Tavazzi L; Tendera M; Felix SB; Dominguez F; Ojrzynska N; Losi MA; Limongelli G; Barriales-Villa R; Seferovic PM; Biagini E; Wybraniec M; Laroche C; Caforio ALP;
    Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):781-789. PubMed ID: 33417664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies.
    Grothoff M; Pachowsky M; Hoffmann J; Posch M; Klaassen S; Lehmkuhl L; Gutberlet M
    Eur Radiol; 2012 Dec; 22(12):2699-709. PubMed ID: 22772366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of vasodilator stress myocardial contrast echocardiography and magnetic resonance imaging for the differential diagnosis of ischemic versus nonischemic cardiomyopathy.
    Mor-Avi V; Koch R; Holper EM; Goonewardena S; Coon PD; Min JK; Fedson S; Ward RP; Lang RM
    J Am Soc Echocardiogr; 2008 May; 21(5):425-32. PubMed ID: 18187290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.
    Romano S; Judd RM; Kim RJ; Kim HW; Klem I; Heitner JF; Shah DJ; Jue J; White BE; Indorkar R; Shenoy C; Farzaneh-Far A
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1419-1429. PubMed ID: 29361479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
    Keil L; Chevalier C; Kirchhof P; Blankenberg S; Lund G; Müllerleile K; Magnussen C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
    Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.
    Kouranos V; Tzelepis GE; Rapti A; Mavrogeni S; Aggeli K; Douskou M; Prasad S; Koulouris N; Sfikakis P; Wells A; Gialafos E
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1437-1447. PubMed ID: 28330653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of cardiovascular magnetic resonance imaging in children with myocardial diseases.
    Ziółkowska L; Śpiewak M; Małek Ł; Boruc A; Kawalec W
    Kardiol Pol; 2015; 73(6):419-28. PubMed ID: 25563465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Role of CMR and Conventional Risk Factors in Myocardial Infarction With Nonobstructed Coronary Arteries.
    Dastidar AG; Baritussio A; De Garate E; Drobni Z; Biglino G; Singhal P; Milano EG; Angelini GD; Dorman S; Strange J; Johnson T; Bucciarelli-Ducci C
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1973-1982. PubMed ID: 30772224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac magnetic resonance in hypertrophic and dilated cardiomyopathies.
    Pradella S; Grazzini G; De Amicis C; Letteriello M; Acquafresca M; Miele V
    Radiol Med; 2020 Nov; 125(11):1056-1071. PubMed ID: 32946001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Non-invasive Imaging Techniques in Chronic Heart Failure and Cardiomyopathies : Focus on Cardiac Magnetic Resonance Imaging and Computed Tomographic.
    Di Bella G; Pizzino F; Donato R; Di Nunzio D; de Gregorio C
    Adv Exp Med Biol; 2018; 1067():183-196. PubMed ID: 29498024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Outcomes in Patients with Chronic Ischemic Cardiomyopathy by Layer-Specific Strain Echocardiography: A Proof of Concept.
    Hamada S; Schroeder J; Hoffmann R; Altiok E; Keszei A; Almalla M; Napp A; Marx N; Becker M
    J Am Soc Echocardiogr; 2016 May; 29(5):412-20. PubMed ID: 26969138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).
    Paterson I; Wells GA; Ezekowitz JA; White JA; Friedrich MG; Mielniczuk LM; O'Meara E; Chow B; DeKemp RA; Klein R; Dennie C; Dick A; Coyle D; Dwivedi G; Rajda M; Wright GA; Laine M; Hanninen H; Larose E; Connelly KA; Leong-Poi H; Howarth AG; Davies RA; Duchesne L; Yla-Herttuala S; Saraste A; Farand P; Garrard L; Tardif JC; Arnold M; Knuuti J; Beanlands R; Chan KL
    Trials; 2013 Oct; 14():332. PubMed ID: 24119686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.